Skip to content

MBCP+

by Biomatlante 2 variants

510(k) K063527

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

1 closed

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK063527 Date30 Jul 2007ClearedStatusActive

Official records

From the FDA record

Received by the FDA
22 Nov 2006
FDA decision
30 Jul 2007 (Substantially Equivalent)
FDA review time
250 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K063527 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

1 recall · FDA

    • Terminated Z-1677-2011 FDA Unclassified (pre-2012) initiated 31 Jan 2011

    The OsteoMatrix Synthetic Bone Graft Composite Instructions for Use document, P4G10A/Rev. 01 had language that was not consistent with the cleared indications.

Timeline

2 dated events

  1. Cleared FDA 510(k) K063527
  2. Recall initiated FDA recalls Z-1677-2011

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
MQV
Device class
Class II
Regulation
21 CFR Part 888.3045
Advisory committee
Orthopedic
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 22 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

MBCP+ is a fully synthetic bone graft matrix used as an alternative to biologic osteoinductive products. It is a 3D interconnected matrix that mimics the trabecular architecture and thin crystalline structure of natural bone. The device provides optimal permeability for cell migration and angiogenesis.

MBCP+ is supplied as granules in 0.5-1.0mm size with 0.25cc volume. It is a synthetic device that has received FDA 510(k) clearance with the product code MQV. The device is intended for use in bone grafting procedures, particularly in the treatment of long bone non-union fractures.

Similar devices

Other devices filed under FDA product code MQV (Filler, Bone Void, Calcium Compound).

Other devices from Biomatlante

  • Mbcp+® 0701M+G25

    Class II
  • Mbcp+® 0701M+G02

    Class II
  • Mbcp+® 0701M+GS50

    Class II
  • Mbcp+® 0701M+G50

    Class II

See all devices from Biomatlante →